Haemostasis, thrombosis & embolism Flashcards

1
Q

What is haemostasis?

A

The process by which bleeding from an injured vessel is arrested or reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What sequence of events does haemostasis involve?

A
  • vascular spasm
  • platelet aggregation, activation and release of chemical mediators - platelet plug formation
  • blood coagulation cascade - blood clotting
  • Clot repair
  • removal of the clot - allowing repair → fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is thrombosis?

A

Haemostasis in the wrong place

  • e.g. blood clotting within veins or platelet activation within arteries
  • a thrombus can travel in he circulation as an embolus and block the arterial and venous circulation - pulmonary embolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe vasospasm

A
  • injury to vessel endothelium leads to contractile response
  • this lowers downstream BP
  • in addition, the upstream arterioles and small arteries construct, limiting blood flow to damaged areas
  • designed to limit bleeding
  • reduced blood flow also facilitates contact activation of platelets and coagulation factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the initial trigger for vasospasm and what takes over?

A
  1. initially it is trauma

2. then, local factors (e.g. serotonin, bradykinin and thromboxane A2) from platelets mediate the constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What features of the vessel endothelium prevent clotting?

A

Surface heparan sulphate acts as a co-factor for anti-thrombin III and thus prevents platelet aggregation and coag cascade initiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What pro-thrombogenic molecules may be released from the vessel endothelium in response to damage?

A
  1. tissue factor → activates extrinsic clotting pathway
  2. Von Willebrand factor → enables binding of platelets to damaged vesicles
  3. Plasminogen activator inhibitor 1 → secreted in response to angiotensin - inhibits removal of clots that are forming
  4. collagen → leads to platelet aggregation through binding of receptors on the surface
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How may the vascular endothelium limit coagulation to allow healing?

A
  1. PGI2 and NOs → ADP to adenosine which inhibits platelet function
  2. Tissue plasminogen activator → accelerates plasmin formation and clot removal
  3. Thrombomodulin → activates anti-coagulant, protein C
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe platelets

A
  • no nucleus, mitochondria, little ER
  • lots of granules and vacuoles
  • alpha granules contain fibrinogen
  • delta granules contain ADP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe platelet adhesion

A

Following changes in the vascular endothelial lining, platelets adhere to the damaged endothelial cells and sub-endothelial tissues. This adhesion is mediated byglycoproteinson the platelet surface

		- Glycoprotein Ia– Binds directly to the exposedcollagen, leading to adhesion
		- Glycoprotein Ib– Binds tovon Willebrand factor, which then binds tosubendothelial macromolecules, allowing platelet adhesion  - Glycoprotein VI– Binds collagen and snake venom. Snake venom can coagulate all of the blood in the entire body very quickly, as it bypasses the need to bind collagen and therefore the need for actual tissue damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens to the platelets following adhesion?

A

They can change shape

Change from smooth discs to spiny spheres with protruding pseudopodia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What leads to platelet activation and what does activation mean?

A
  • adhesion to collage and thrombin exposure = activation of platelets
  • release of their granule contents
  • collagen and thombin activate platelet prostaglandin G2 and H2 synthesis from arachidonic acid
  • prostaglandin then initiate synthesis of thromboxane A2 which lowers cAMP
  • decreases in cAMP increase the conc of Ca2+ which induces the release of granules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the two types of platelet storage granule

A

a-granules
○ Pro-coagulant molecules– E.g.platelet factor 3.These interact with the clotting cascade to accelerate the formation of a fibrin clot, which can stabilize the initial platelet plug
○ Fibrinogen– Important in the formation of the fibrin clot and platelet aggregation
○ PDGF(platelet derived growth factor) – Initiates simultaneousvascular repair
○ Thrombospondin, fibronectin and von Willebrand factor

Dense bodies(dgranules)
○ Serotonin– Induce vasoconstriction
○ ADP– Induces a conformational change in theGPIIb/IIIareceptor,allowing it to bind tofibrinogenand thus localize platelet aggregation and blood clot formation to the site of injury. ADP can alsofeed backto cause further activation of platelets
○ ATP, GDP, GTP and calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does platelet aggregation form?

A

An unstable primary haemostatic plug

This is subsequently stabilized by fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the mechanism behind aggregation

A

Various agonists, includingcollagen, thrombin, ADP and thromboxane A2(ADP and TXA2are the key mediators)act on receptors at the platelet surface. These induce the expression ofGPIIb/IIIa receptors (integrin family receptors)on the surface of the platelets. These receptors bindfibrinogen, which is present in the plasma, and thus enable the formation of links between adjacent platelets. This draws platelets together and thus leads to aggregation. Binding of fibrinogen to these receptors inducesfurther degranulation, which in turn induces more GPIIb/IIIa receptor expression, and thus the process is self-perpetuating.

TheGPIIb/IIIareceptor can be targeted by monoclonal antibodies foruse in arterial stenting procedures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe clot stabilisation by fibrin

A

Exposure ofacidic phospholipidson the outer surface of platelets activates the formation ofthrombin, which in turn is able tocleave fibrinogen to fibrin. Fibrin polypeptides form a meshwork with the primary platelet clot, and thereforestabilise the plug. In addition, thisactivates further plateletsthroughthrombin receptorson the platelet surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does contraction of the clot occur?

A

Following the formation of the clot, it is thoughtCa2+releasewithin platelets, stimulated bythrombin, activatescontractile proteins. This results inretractionof the clot. In addition, as the clot evolves platelets become fused together (stimulated by ADP, thrombin and factors from the release action), which further stabilises the clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does the clotting cascade describe?

A

the process by which fluid is converted into a solid gel or clot

19
Q

What is the main event in the clotting cascade?

A

Conversion of soluble plasma fibrinogen into insoluble strands of fibrin
This creates a mesh that can bind blood components - platelets in particular

20
Q

What are the 3 broad stages of the clotting cascade?

A
  1. Formation ofprothrombin activating factor (factor Xa – 10a) by a chemical cascade in response totrauma
  2. Conversion ofinactive prothrombin to active thrombinbyfactor Xa.
  3. Conversion ofsoluble fibrinogen to insoluble fibrinbythrombin.Fibrin enmeshes platelets, blood cells and plasma to form a stable clot.
21
Q

How is there amplification in the clotting cascade?

A

A single serine protease is able to cleave many zymogen molecules (clotting factor precursors)
Positive feedback

22
Q

When is the extrinsic pathway activated?

A

When blood comes into contact with products of damaged tissue

23
Q

When is the intrinsic pathway activated?

A

When blood comes into contact with damaged surface (e.g. collagen) or artificial surface (e.g. glass, catheter)

24
Q

Describe the extrinsic pathway

A

The most important factor istissue factor, an integral membrane protein released by damaged cells. Tissue factoractivates factor VIIby inducing autocatalytic cleavage in the presence of Ca2+ions. Factor VIIa interacts with phospholipids provided by activated platelets, and convertsfactor X to Xa. This is the most important clotting pathwayin vivo

25
Q

Describe intrinsic pathway

A

Activated when blood comes into contact with adamaged surface (e.g. collagen) or artificial surface(e.g. glass, catheter, prosthetic heart valves – As a resultanticoagulantsneed to be give in conjunction) –Factor XIIadheres to a negatively charged surface. This involves a cascade offactors XII, XI, IX and VIII.

	This results in the formation ofIXa, which in conjunction withVIIIa,plateletphospholipids and Ca2+ionsalso results in the cleavage of factorX to Xa. This is aslower responseand all necessary elements are present within the blood. It mainly occursin vitro, with debate as to its physiological role, since factor XII deficiency has little effect on in vivo clotting.
	
	Factor XIIIais the crucial modifier in the intrinsic pathway, resulting in a200,000-fold increasein the production of factor Xa.Factor XIIIisactivated by thrombin, forming a positive feedback loop
26
Q

What is the final product of both pathways?

A

factor X to factor Xa conversion

27
Q

What is Xa known as and what does it do?

A

Prothrombin activatorIn the presence of Ca2+ions, platelet phospholipids and factor Va, prothrombin activator cleavesprothrombin (II) to thrombin (IIa).It is therefore the main enzyme in the cascade.This reaction occurs on thesurface of an activated platelet

28
Q

Why is vitamin K important in the clotting cascade?

A

essential for the production offactors II, VII, IX and X
Deficiency in vitamin K(E.g. due to impaired fact absorption) can therefore lead tobleeding.Low vitamin K levels in neonates can lead tohaemorrhagic diseaseof the newborn. Thus, babies receive anintramuscular injectionof the vitamin at birth. Vitamin K is found inbroccoli!

29
Q

Draw trick for remembering extrinsic and intrinsic pathways

A

OneNote

30
Q

What three processes govern regulation of clotting?

A

1 - dilution - clotting factors washed to liver by blood flow
2 - clotting inhibitors
Clotting inhibitors act directly on factors within the cascade to inhibit their function
○ Antithrombin III– This is an anticoagulant made by theendothelial cells and the liver. It inhibits allserine proteaseswithin the cascade. It is particularly important in inactivating tissuefactor-VIIa, and thus theintrinsic pathway. This is the target forheparin,which will stabilise theATIII-thrombin interactionby a factor of1000
Protein C– Activated when thrombin binds tothrombomodulin receptorsin the intact epithelium. Assisted by its cofactor,protein S,it binds tofactors Va and VIIa,inactivating them.The net effect is to induce fibrinolysis and anticoagulant activity.It is measured in blood samples to see how much coagulant/anticoagulant activity a patient has.

3 - fibrinolysis

31
Q

Describe fibrinolysis

A

When the clotting system is activated, a set of factors that are able to dissolve away clots are also activated. These help to limit the extension of the clot beyond the region of damage, and also prevent obstruction by dissolving small clots in the circulation, which may have broken off from the main area of, plug formation (emboli)

32
Q

What is the key enzyme in fibrin degradation?

A

Plasmin - active serine protease

It is activated from plasminogen which circulates in blood and is deposited on fibrin

33
Q

Describe haemophilias

A

○ Haemophilia A – X-linked recessive deficiencyinFactor VII
Haemophilia B– Also anX-linked recessive diseasealthough it results in deficiency ofFactor IXand accounts for only10%of all haemophilia cases.

34
Q

What is Virchow’s tirad?

A

describes three primary factors that promote thrombus formation 1. Changes in theintimal surfaceof the vessel

  1. Changes in thepattern of blood flow– E.g. Pooling of blood in the venous system leads to a high risk of venous thrombosis
  2. Changes in blood constituents
35
Q

What are the two types of thrombus?

A

Arterial and venous

36
Q

Changes in blood constituents leading to thrombus - mainly arterial or venous?

A

Venous

37
Q

Describe changes in blood constituents leading to thrombus formation

A

Any of the following factors will leading tohypercoagulabilityand an increased risk of thrombus formation:
○ Increased inprocoagulationfactors – E.g. fibrinogen and factor VII
○ Decrease in anticoagulant factors – E.g. ATIII
○ Increase in blood viscosity – E.g. Polycythaemia (increased number of RBCs)
○ Increase in platelet numbers – Thrombocytosis
○ Increase in platelet adhesiveness or aggregation
○ Presence ofanticardiolipinantibodies such as in systemic lupus erythematosus
○ Release ofprocoagulationfactors by tumours

38
Q

Describe arterial thrombi

A
  • mainly composed of activated platelets with some fibrin (as the process underlying their development, endothelial injury, lead to platelet activation
  • can be caused by atherosclerotic rupture or the release of pro-thrombotic debris duringvascular surgeryorinterventional cardiologyprocedures.
39
Q

Describe venous thrombi

A
  • mainly fibrin with a few platelets and large proportion of RBCs stuck in the mesh
  • tend to form in hypercoaguable states or in conditions where venous flow has stopped (such as with deep vein thromboses cause by extended periods of inactivity or atrial fibrillation where blood pools in the atrial chambers of the heart
40
Q

What is an embolism?

A

abnormal mass transported in the blood stream

41
Q

What are most emboli derived from?

A

Thrombus material

42
Q

Describe origins of pulmonary and systemic emboli

A
  • pulmonary emboli typically occur from deep vein thrombosis, which migrate to the right side of the heart
  • systemic emboli are caused by a thrombus originating in the left side of the heart, which can go on to occlude anywhere in the arterial system
43
Q

What are other causes of embolism?

A
  • fat droplets
  • bubbles of air or nitrogen
  • atherosclerotic debris
  • tumour fragments
  • bits of bone marrow
  • amniotic fluid